64064-71-7

Usage

Uses

Used in Pharmaceutical Research:
6-BROMO-3-NITROIMIDAZO[1,2-A]PYRIDINE is used as a research compound for its potential role in anti-cancer and neurodegenerative disease treatments. Its ability to selectively inhibit CDK 2 and 5 makes it a valuable tool in studying the mechanisms of these diseases and developing targeted therapies.
Used in Organic Synthesis:
In the field of organic synthesis, 6-BROMO-3-NITROIMIDAZO[1,2-A]PYRIDINE serves as a key intermediate or building block in the synthesis of more complex molecules with potential applications in various industries.
Used in Antimicrobial Applications:
6-BROMO-3-NITROIMIDAZO[1,2-A]PYRIDINE is used as an antimicrobial agent, particularly against parasitic infections. Its activity in this area highlights its potential as a component in the development of new treatments for parasitic diseases.
Used in Drug Development:
Due to its unique structure and biological activity, 6-BROMO-3-NITROIMIDAZO[1,2-A]PYRIDINE is used as a lead compound in the development of new drugs and therapeutic treatments. Its potential applications in anti-cancer, neurodegenerative disease treatments, and antimicrobial therapies make it an important compound for further research and development.

InChI:InChI=1/C7H4BrN3O2/c8-5-1-2-6-9-3-7(11(12)13)10(6)4-5/h1-4H

Upstream product

• 6188-23-4 6-bromoimidazo[1,2-a]pyridine 
• 1072-97-5 5-bromo-2-pyridylamine 

Downstream Products

• 64064-73-9 3-amino-6-phenylthioimidazo [1,2-a] pyridine 
• 64064-74-0 (6-phenylsulfanyl-imidazo[1,2-a]pyridin-1-yl)-carbamic acid methyl ester 
• 64064-72-8 3-nitro-6-phenylsulfanyl-imidazo[1,2-a]pyridine 

Relevant academic research and scientific papers

SUBSTITUTED IMIDAZOPYRIDINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS

This application relates to substituted imidazopyridines, compositions comprising them and their uses in the treatment of diseases and conditions in which inhibition of a bromodomain is indicated. For example, the application relates to substituted imidaz

Certain 6-substituted-2-pyridinamines

Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3-position are active anthelmintic agents. The novel compounds are prepared from the appropriate substituted 2-aminopyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.

Substituted imidazo [1,2-a] pyridines

Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3-position are active anthelmintic agents. The novel compounds are prepared from the appropriate substituted 2-aminopyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.

Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group

Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3- position and a heterocyclic moiety on the pyrido portion of the molecule are active anthelmintic agents. The heterocyclic moiety is connected to the imidazo [1,2-a] pyridine molecule through an oxygen, sulfur, sulfinyl or sulfone. The novel compounds are prepared from the appropriately substituted 2-amino pyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.

Certain substituted imidazo [1,2-a] pyridines

Certain novel substituted imidazo [1,2-a] pyridines with a substituted amino group at the 2- or 3-position are active anthelmintic agents. The novel compounds are prepared from the appropriate substituted 2-aminopyridine precursor. Compositions which utilize said novel imidazo [1,2-a] pyridines as the active ingredient thereof for the treatment of helminthiasis are also disclosed.